Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2025-01-06 00:00:00 ET · period of report 2025-01-02 · accession 0001396814-25-000007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-01-06 | 2025-01-06 | PCRX | SLONIN JONATHAN | Chief Medical Off | S - Sale | $18.40 | -879 | 93.4K | -0.9% | -$16.2K | |
| 2025-01-06 | 2025-01-02 | PCRX | SLONIN JONATHAN | Chief Medical Off | F - Tax | $18.33 | -371 | 94.3K | -0.4% | -$6,800 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-06 | S | D | 879 | $18.40 | 93,443.51 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-02 | F | D | 371 | $18.33 | 94,322.51 | D | — | — | (F2) Includes 386.765 shares of common stock acquired under the issuer's employee stock purchase plan in December 2024. |